Ghalib Jibara
Papers
1
Total Citations
10
H-Index
1
About
Ghalib Jibara is a urologic oncologist whose research focuses on improving risk stratification and treatment outcomes for prostate cancer patients. His most impactful work addresses a critical clinical challenge: the overestimation of prostate cancer aggressiveness on biopsy. In a landmark 2017 study, Jibara demonstrated that over half of contemporary clinical Gleason 8 tumors on prostate biopsy are downgraded at radical prostatectomy, revealing a significant discrepancy between biopsy-based risk classification and final pathology. This finding, cited 10 times, challenges current treatment guidelines that rely on the highest Gleason sum in any biopsy core, potentially sparing men from unnecessary aggressive therapy. Jibara's contributions have direct implications for precision medicine in urologic oncology, helping to refine the balance between overtreatment and undertreatment. His work underscores the importance of integrating clinical, pathological, and molecular data to better predict disease behavior, ultimately aiming to personalize prostate cancer management and improve patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1